Hip Fracture, Proximal Femoral Fracture
Conditions
Keywords
Hip, Hip endoprosthesis, Hip fracture, Femoral fracture, Bone cement, Non-cemented
Brief summary
The hip semiendoprosthesis is an acceptable method to treat the proximal femoral fractures. Traditionally, the cemented version of the semiendoprosthesis has been used for this indication. However, the cementing carries a risk of fat embolism during the pressurization of the cement. The fat embolism can be avoided when using the non-cemented semiendoprosthesis. In this study we want to find out whether there are any differences in the treatment results between the cemented and non-cemented semiendoprostheses when treating the proximal femoral fractures.
Interventions
DEVICECemented semiendoprosthesis
Application of a cemented semiendoprosthesis (Basis, Smith & Nephew)
DEVICEnon-cemented
Patients are treated with a non-cemented semiendoprosthesis (Biomet Taperloc, Biomet Inc.)
Sponsors
The Finnish Research Foundation for Orthopaedics and Traumatology
Kuopio University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* A proximal femoral fracture
Exclusion criteria
* Rheumatoid arthritis * Pathologic fracture * Severe dementia (preventing the informed consent)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary mortality | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Prosthetic complications | 1 year |
Countries
Finland
Outcome results
None listed